The Motley Fool
OCTOBER 20, 2024
With equity stakes in successful businesses such as Palantir Technologies and Axsome Therapeutics , this business development company's ( BDC ) regular quarterly dividend has held steady or risen since 2009. That said, success for one can offset dozens of failures.
The Motley Fool
APRIL 28, 2024
Let's break down five companies that are established dividend payers, and assess why holding each of these stocks over a long-term time horizon can lead to massive gains for your portfolio. Hercules Capital Hercules Capital (NYSE: HTGC) is a business development company (BDC). per unit at the end of 2009, to $3.70
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Motley Fool
AUGUST 12, 2024
Pfizer With products that many of us can't live without, pharmaceutical companies tend to pay dividends that are relatively reliable. Pfizer has raised its payout every year since 2009, but a market concerned about slowing sales is pressuring its stock price lower. At recent prices, the pharma company offers a 5.9%
The Motley Fool
OCTOBER 24, 2024
Ares Capital is a business development company ( BDC ) that provides financing for middle-market companies (businesses that generate between $10 million and $250 million in earnings before interest, taxes, depreciation, and amortization ( EBITDA ) every year). Should you invest in it today?
The Motley Fool
DECEMBER 21, 2023
It's in a category of investments called business development companies , or BDCs. As the name suggests, these outfits help up-and-coming companies become all they can be. However, after 14 straight years of steady or increased annualized dividend payments (from 2009's $0.37
The Motley Fool
JUNE 14, 2023
Ares Capital: A 10.05% yield Ares Capital (NASDAQ: ARCC) is a business development company, or BDC. Ares Capital is essentially a lender to midsized companies that have a hard time getting the big banks to return their calls. Ares Capital's dividend hasn't risen in a straight line, but it has increased by 37% since 2009.
The Motley Fool
AUGUST 10, 2024
Pfizer has raised its dividend payout every year since 2009; at recent prices, it offers a 5.8% Sales of Pfizer's COVID-19 products fell faster than expected but not before the company reinvested heaps of the revenue they generated back into its development pipeline. dividend yield.
Expert insights. Personalized for you.
244 
Let's personalize your content